The PE Ratio as of November 2024 (TTM) for Clene Inc. (CLNN) is -0.79

According to Clene Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.79. This represents a change of -33.96% compared to the average of -1.20 of the last 4 quarters.

Clene Inc. (CLNN) Historical PE Ratio (quarterly & annually)

How has CLNN PE Ratio performed in the past?

The mean historical PE Ratio of Clene Inc. over the last ten years is -36372.90. The current -0.79 PE Ratio has changed -99.78% with respect to the historical average. Over the past ten years (40 quarters), CLNN's PE Ratio was at its highest in in the December 2020 quarter at 207.78. The PE Ratio was at its lowest in in the June 2021 quarter at -51.29.

Clene Inc. (CLNN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clene Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clene Inc. (CLNN) Average PE Ratio

How has CLNN PE Ratio performed in the past?

The current PE Ratio of Clene Inc. (CLNN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Clene Inc. (CLNN) PE Ratio vs. Peers

How is CLNN’s PE Ratio compared to its peers?

Clene Inc.’s PE Ratio is less than MediciNova, Inc. (0), less than Eliem Therapeutics, Inc. (-0.04), greater than Molecular Partners AG (-2.42), greater than Champions Oncology, Inc. (-2.50), greater than Cyteir Therapeutics, Inc. (-18.21), greater than Century Therapeutics, Inc. (-9.12), less than Kezar Life Sciences, Inc. (-0.79), greater than Mineralys Therapeutics, Inc. (-5.71), greater than Nkarta, Inc. (-4.06), greater than NGM Biopharmaceuticals, Inc. (-1.63), greater than Ikena Oncology, Inc. (-1.35), greater than Foghorn Therapeutics Inc. (-1.38), greater than Werewolf Therapeutics, Inc. (-5.38), greater than Immunome, Inc. (-1.34), greater than Sensei Biotherapeutics, Inc. (-1.94), less than NextCure, Inc. (-0.44), less than Nuvation Bio Inc. (-0.57), greater than Graphite Bio, Inc. (-1.44), less than Merrimack Pharmaceuticals, Inc. (-0.13), greater than null (-8.92),

Build a custom stock screener for Clene Inc. (CLNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clene Inc. (CLNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.